thiazoles has been researched along with gnidimacrin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, W; Heike, Y; Ikekawa, T; Nishio, K; Saijo, N; Takahashi, M; Wakasugi, H; Yoshida, M | 1 |
1 other study(ies) available for thiazoles and gnidimacrin
Article | Year |
---|---|
Antitumor action of the PKC activator gnidimacrin through cdk2 inhibition.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Northern; Blotting, Western; CDC2-CDC28 Kinases; cdc25 Phosphatases; Cell Cycle; Coloring Agents; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Diterpenes; Dose-Response Relationship, Drug; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Humans; K562 Cells; Mice; Models, Biological; Models, Chemical; Phosphorylation; Precipitin Tests; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2001 |